Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Claudiani

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
British Journal of Haematology|October 28, 2021
Is COVID-19 less severe in CML patients than in those with other haematological cancers?Simone Claudiani
Hematology. American Society of Hematology. Education Program|December 4, 2018
The argument for using imatinib in CMLSimone Claudiani, Jane F Apperley
British Journal of Haematology|May 30, 2026
Further insights into the application of the TFR prognostic score (TPS) in CML patients attempting TFRSimone Claudiani, Silvia Metelli, Dragana Milojkovic
Leukemia & Lymphoma|June 25, 2019
The influence of salivary amylase on total amylase elevation in CML patients treated with TKI therapy: a case series of 3 patientsGeorge Nesr, Simone Claudiani, Jamshid Khorashad, et al.
Haematologica|September 21, 2019
Prolonged treatment-free remission in chronic myeloid leukemia patients with previous <i>BCR-ABL1</i> kinase domain mutationsSimone Claudiani, Jane F Apperley, Afzal Khan, et al.
Leukemia & Lymphoma|July 14, 2020
Platelet function in patients with chronic myeloid leukemia treated with asciminibGeorge Nesr, Mike Laffan, Simone Claudiani, et al.
British Journal of Haematology|August 4, 2017
Development of artificial bone marrow fibre scaffolds to study resistance to anti-leukaemia agentsMahroo Karimpoor, Eranka IIlangakoon, Alistair G Reid, et al.
American Journal of Hematology|July 29, 2016
Cognitive dysfunction after withdrawal of tyrosine kinase inhibitor therapy in chronic myeloid leukaemiaSimone Claudiani, Jane F Apperley, Simona Deplano, et al.
Ejhaem|October 6, 2025
Changes in Common Blood Parameters After Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid LeukaemiaFiona Fernando, Claudia Wasko, Bronwen Johns, et al.
Leukemia & Lymphoma|June 12, 2019
Blast crisis of chronic myeloid leukemia with plasmacytoid dendritic cell phenotype associated with a rare fusion transcript, e13a3 BCR-ABL1Danmei Xu, Simone Claudiani, Kikkeri Naresh, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
British Journal of Haematology|October 28, 2021
Is COVID-19 less severe in CML patients than in those with other haematological cancers?Simone Claudiani
Hematology. American Society of Hematology. Education Program|December 4, 2018
The argument for using imatinib in CMLSimone Claudiani, Jane F Apperley
British Journal of Haematology|May 30, 2026
Further insights into the application of the TFR prognostic score (TPS) in CML patients attempting TFRSimone Claudiani, Silvia Metelli, Dragana Milojkovic
Leukemia & Lymphoma|June 25, 2019
The influence of salivary amylase on total amylase elevation in CML patients treated with TKI therapy: a case series of 3 patientsGeorge Nesr, Simone Claudiani, Jamshid Khorashad, et al.
Haematologica|September 21, 2019
Prolonged treatment-free remission in chronic myeloid leukemia patients with previous <i>BCR-ABL1</i> kinase domain mutationsSimone Claudiani, Jane F Apperley, Afzal Khan, et al.
Leukemia & Lymphoma|July 14, 2020
Platelet function in patients with chronic myeloid leukemia treated with asciminibGeorge Nesr, Mike Laffan, Simone Claudiani, et al.
British Journal of Haematology|August 4, 2017
Development of artificial bone marrow fibre scaffolds to study resistance to anti-leukaemia agentsMahroo Karimpoor, Eranka IIlangakoon, Alistair G Reid, et al.
American Journal of Hematology|July 29, 2016
Cognitive dysfunction after withdrawal of tyrosine kinase inhibitor therapy in chronic myeloid leukaemiaSimone Claudiani, Jane F Apperley, Simona Deplano, et al.
Ejhaem|October 6, 2025
Changes in Common Blood Parameters After Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid LeukaemiaFiona Fernando, Claudia Wasko, Bronwen Johns, et al.
Leukemia & Lymphoma|June 12, 2019
Blast crisis of chronic myeloid leukemia with plasmacytoid dendritic cell phenotype associated with a rare fusion transcript, e13a3 BCR-ABL1Danmei Xu, Simone Claudiani, Kikkeri Naresh, et al.
Pageof 4